시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 만성 정맥 폐색 치료 시장 보고서(2025년)
Chronic Venous Occlusions Treatment Global Market Report 2025
상품코드 : 1682060
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,324,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,141,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,958,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

만성 정맥 폐색 치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 6.7%로 성장할 전망이며, 93억 2,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 정맥 질환에 대한 의식 고조, 저침습 수술에 대한 수요 증가, 인구의 고령화, 혈관내 치료의 진보, 환자 중심 케어에 대한 주력 등에 기인할 것으로 보입니다. 예측 기간 주요 동향으로는 저침습 수술의 진보, 인터벤셔널 라디오로지에 있어서 기술 혁신, 혈관내 치료에 대한 주력, 정맥 질환 유병률의 증가, 고령화 인구 증가 등을 들 수 있습니다.

예상되는 비만 증례 증가는 향후 만성 정맥 폐색 치료 시장의 성장을 견인할 것으로 보입니다. 비만증은 체지방의 과도한 축적으로 인해 체격지수(BMI)가 30 이상 되는 것을 특징으로 하며, 부종 및 피부 변화 등의 증상을 동반할 수 있습니다. 만성 정맥 폐색 치료는 혈류를 개선하고 염증을 억제함으로써 이러한 증상을 관리하고 효과적인 비만 관리에 기여하는 중요한 역할을 담당하고 있습니다. 세계심장연맹이 2023년 3월에 보고한 것처럼 전 세계적으로 약 23억 명의 성인 및 소아가 비만 또는 과체중입니다. 현재 비만 동향으로는 2025년까지 비만인 사람의 수가 27억 명에 이를 것으로 예측되고 있습니다. 따라서 비만 유병률 증가가 만성 정맥 폐색 치료 시장의 성장을 촉진하는 중요한 요인이 되고 있습니다.

저침습 절차의 채용 확대가 만성 정맥 폐색 치료 시장의 성장을 견인할 것으로 전망됩니다. 저침습 처치는 큰 외과적 절개와는 대조적으로 작은 절개 및 자연스러운 신체 개구부를 통해 이루어지는 의료 및 외과 기술을 포함합니다. 이러한 손기술은 감염증, 출혈, 흉터 등의 합병증 위험을 낮추는 것으로 이어집니다. 만성 정맥 폐색 환자에게는 더욱 건강상의 우려가 있는 경우가 많기 때문에 합병증의 위험을 최소화하는 것은 환자 전체의 건강에 필수적입니다. 예를 들면, 2024년 6월, 영국을 거점으로 하는 인정 성형 외과 의사를 위한 전문 조직인 국제 미용 성형 외과 학회(ISAPS)는, 2023년 외과 수술 및 비외과 수술의 총수가 3.4% 증가했으며, 3,490만 건에 달했다고 보고했습니다. 지방 흡입술은 유방확대술을 뛰어넘어 여성들 사이에서 가장 인기 있는 수술법으로 떠올랐고, 180만 건의 수술이 진행되어 2021년부터 29% 증가했습니다. 따라서 저침습 수술의 채택이 증가하고 있으며 만성 정맥 폐색 치료 시장의 성장에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장-금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Chronic venous occlusion refers to the prolonged blockage or obstruction of veins, commonly occurring in the legs or arms, which can hinder blood flow and result in various health issues such as swelling, pain, and skin changes. Treatment aims to alleviate symptoms, slow down the disease's progression, and prevent complications.

The primary categories of products within chronic venous occlusion treatment include devices and drugs. Devices encompass instruments, apparatuses, machines, or implants utilized for prevention, diagnosis, or treatment. In chronic venous occlusion treatment, devices play a crucial role in restoring proper blood flow and enhancing overall venous health, contributing to the success of treatment outcomes. These applications span various conditions, including varicose veins, venous stasis ulcers, edema, deep vein thrombosis, and others. They are utilized by hospitals, clinics, ambulatory surgery centers, trauma centers, and other healthcare facilities.

The chronic venous occlusions treatment market research report is one of a series of new reports from The Business Research Company that provides chronic venous treatment market statistics, including chronic venous occlusions treatment industry global market size, regional shares, competitors with a chronic venous occlusions treatment market share, detailed chronic venous occlusions treatment market segments, market trends and opportunities, and any further data you may need to thrive in the chronic venous occlusions treatment industry. This chronic venous occlusions treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic venous occlusions treatment market size has grown strongly in recent years. It will grow from $6.7 billion in 2024 to $7.19 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to investments in treatment innovation, rise in venous disorder prevalence, awareness and diagnosis improvement, clinical trials and research initiatives, improved patient outcomes and quality of life.

The chronic venous occlusions treatment market size is expected to see strong growth in the next few years. It will grow to $9.32 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rise in venous disorders awareness, rising demand for minimally invasive procedures, ageing population dynamics, advancements in endovascular therapies, focus on patient-centric care. Major trends in the forecast period include advancements in minimally invasive procedures, technological innovations in interventional radiology, focus on endovascular therapies, growing prevalence of venous disorders, rise in aging population.

The anticipated rise in obesity cases is set to drive the growth of the chronic venous occlusion treatment market in the future. Obesity, characterized by an excessive accumulation of body fat leading to a body mass index (BMI) of 30 or higher, can be associated with symptoms such as edema and skin changes. Chronic venous occlusion treatment plays a crucial role in managing these symptoms by improving blood flow and reducing inflammation, contributing to effective obesity management. As reported in March 2023 by the World Heart Federation, around 2.3 billion adults and children globally were either obese or overweight. With the current obesity trend, it is projected that the number of individuals with obesity will reach 2.7 billion by 2025. Therefore, the increasing prevalence of obesity is a key factor propelling the growth of the chronic venous occlusion treatment market.

The growing adoption of minimally invasive procedures is expected to drive the growth of the chronic venous occlusions treatment market. Minimally invasive procedures involve medical and surgical techniques performed through small incisions or natural body openings, as opposed to large surgical cuts. These techniques are linked to a lower risk of complications such as infections, bleeding, and scarring. Since patients with chronic venous occlusions often have additional health concerns, minimizing the risk of complications is vital for their overall health. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a UK-based professional organization for certified plastic surgeons, reported that in 2023, the total number of both surgical and non-surgical procedures grew by 3.4%, reaching 34.9 million. Liposuction emerged as the most popular surgical procedure among women, surpassing breast augmentation, with 1.8 million procedures performed-a 29% increase since 2021. Therefore, the rising adoption of minimally invasive procedures is fueling the growth of the chronic venous occlusion treatment market.

Key players in the chronic venous occlusion treatment market are concentrating on developing innovative solutions, such as implantable medical devices designed to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). An implantable medical device is a device surgically placed inside the body for long-term use, typically for diagnosing, treating, or monitoring medical conditions. For example, in June 2024, Koninklijke Philips N.V. (Philips), a technology company based in the Netherlands, launched the Duo Venous Stent System, an implantable medical device. The Duo Venous Stent System features a dual-layer design that enhances flexibility and radial strength for optimal vein support. Its advanced coating improves biocompatibility and reduces the risk of thrombosis, while the precise delivery system ensures accurate placement in challenging anatomical conditions.

In January 2022, Koninklijke Philips N.V. (Philips) acquired Vesper Medical, a biotechnology company based in Canada, for an undisclosed amount. This acquisition strengthens Philips' portfolio in vascular health solutions, enabling the development of advanced treatments for venous diseases. The move positions Philips to capitalize on innovative technologies, which could increase its market share and enhance patient outcomes in the expanding vascular intervention market. Vesper Medical specializes in the treatment of deep venous disease.

Major companies operating in the chronic venous occlusions treatment market report are Cardinal Health Inc., Bayer AG, Sanofi S.A., 3M Company, Bristol-Myers Squibb Company, Medtronic PLC, Becton, Dickinson and Company (BD), Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Ethicon Inc., Philips Medical Systems, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Integer Holdings Corporation, Penumbra Inc., Inari Medical, Argon Medical Devices Inc., AngioDynamics Inc., Rontis Corporation, Endologix, Richard Wolf GmbH, SIGVARIS AG, enVVeno Medical Corporation, LimFlow SA

North America was the largest region in the chronic venous occlusions treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic venous occlusions treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chronic venous occlusions treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chronic venous occlusion treatment market consists of revenues earned by entities by providing services such as magnetic resonance imaging (MRI), fluoroscopy, computerized tomography (CT) scanning, anticoagulation therapy, and surgical intervention. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic venous occlusion treatment market also includes sales of anticoagulants, thrombolytic agents, pain relievers, and anti-inflammatory drugs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Venous Occlusions Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic venous occlusions treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for chronic venous occlusions treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic venous occlusions treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Chronic Venous Occlusions Treatment Market Characteristics

3. Chronic Venous Occlusions Treatment Market Trends And Strategies

4. Chronic Venous Occlusions Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chronic Venous Occlusions Treatment Growth Analysis And Strategic Analysis Framework

6. Chronic Venous Occlusions Treatment Market Segmentation

7. Chronic Venous Occlusions Treatment Market Regional And Country Analysis

8. Asia-Pacific Chronic Venous Occlusions Treatment Market

9. China Chronic Venous Occlusions Treatment Market

10. India Chronic Venous Occlusions Treatment Market

11. Japan Chronic Venous Occlusions Treatment Market

12. Australia Chronic Venous Occlusions Treatment Market

13. Indonesia Chronic Venous Occlusions Treatment Market

14. South Korea Chronic Venous Occlusions Treatment Market

15. Western Europe Chronic Venous Occlusions Treatment Market

16. UK Chronic Venous Occlusions Treatment Market

17. Germany Chronic Venous Occlusions Treatment Market

18. France Chronic Venous Occlusions Treatment Market

19. Italy Chronic Venous Occlusions Treatment Market

20. Spain Chronic Venous Occlusions Treatment Market

21. Eastern Europe Chronic Venous Occlusions Treatment Market

22. Russia Chronic Venous Occlusions Treatment Market

23. North America Chronic Venous Occlusions Treatment Market

24. USA Chronic Venous Occlusions Treatment Market

25. Canada Chronic Venous Occlusions Treatment Market

26. South America Chronic Venous Occlusions Treatment Market

27. Brazil Chronic Venous Occlusions Treatment Market

28. Middle East Chronic Venous Occlusions Treatment Market

29. Africa Chronic Venous Occlusions Treatment Market

30. Chronic Venous Occlusions Treatment Market Competitive Landscape And Company Profiles

31. Chronic Venous Occlusions Treatment Market Other Major And Innovative Companies

32. Global Chronic Venous Occlusions Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Venous Occlusions Treatment Market

34. Recent Developments In The Chronic Venous Occlusions Treatment Market

35. Chronic Venous Occlusions Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기